Last reviewed · How we verify
TPN171H tablet plus alcohol
At a glance
| Generic name | TPN171H tablet plus alcohol |
|---|---|
| Sponsor | Vigonvita Life Sciences |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of the Hemodynamic Interactions of TPN171H Tablets & Alcohol in Healthy Male Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TPN171H tablet plus alcohol CI brief — competitive landscape report
- TPN171H tablet plus alcohol updates RSS · CI watch RSS
- Vigonvita Life Sciences portfolio CI